学科主题临床医学
Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries
Omata, Masao1,2; Kanda, Tatsuo3; Yokosuka, Osamu3; Crawford, Darrell4; Al-Mahtab, Mamun5; Wei, Lai6; Ibrahim, Alaaeldin7; Lau, George K. K.8,9; Sharma, Barjesh C.10; Hamid, Saeed S.11; Chuang, Wan-Long12; Dokmeci, A. Kadir13
关键词Asian Pacific countries HCV IL28B Direct-acting antivirals
刊名HEPATOLOGY INTERNATIONAL
2015-10-01
DOI10.1007/s12072-015-9630-4
9期:4页:486-507
收录类别SCI
文章类型Review
WOS标题词Science & Technology
类目[WOS]Gastroenterology & Hepatology
资助者Chugai Pharmaceutical ; MSD ; Sumitomo Dainippon Pharma ; Tanabe-Mitsubishi ; Ajinomoto ; Bristol-Myers Squibb ; Daiichi-Sankyo ; Janssen Pharmaceutical ; Bayer ; Abbvie ; Gilead ; GlaxoSmithKline ; Chugai Pharmaceutical ; MSD ; Sumitomo Dainippon Pharma ; Tanabe-Mitsubishi ; Ajinomoto ; Bristol-Myers Squibb ; Daiichi-Sankyo ; Janssen Pharmaceutical ; Bayer ; Abbvie ; Gilead ; GlaxoSmithKline
研究领域[WOS]Gastroenterology & Hepatology
关键词[WOS]SUSTAINED VIROLOGICAL RESPONSE ; RANDOMIZED CONTROLLED-TRIAL ; HEALTH-CARE WORKERS ; INTERFERON-ALPHA-2B PLUS RIBAVIRIN ; CHRONIC LIVER-DISEASES ; CHRONIC-RENAL-FAILURE ; LONG-TERM EFFICACY ; CHRONIC GENOTYPE 2 ; BLOOD-DONORS ; RISK-FACTORS
英文摘要

Estimated hepatitis C virus (HCV) infection rates in the general populations were 1.3, 0.9, 0.4-1.0, 14.7, 0.1-0.3, 0.9-1.9, 1.0-2.0, 5, 4.4-8.6 and 0.5-1.3 % in Australia, Bangladesh, Mainland China, Egypt, Hong Kong, India, Japan, Pakistan, Taiwan and Turkey, respectively. The main HCV genotypes (Gs) are G1, G3, G1b, G4, G1b, G3, G1b, G3, G1b and G2, and G1 in Australia, Bangladesh, Mainland China, Egypt, Hong Kong, India, Japan, Pakistan, Taiwan and Turkey, respectively. Of IL28B genotypes, favorable alleles are similar to 50 % in Australia and Turkey, but 60-70 % in most of the other Asian countries. Peginterferon plus ribavirin is available in all ten Asian Pasific countries. In addition, HCV NS3/4A protease inhibitors with peginterferon plus ribavirin are currently available in several countries. Clinical trials of interferon-free regimens for HCV are ongoing in most of the ten Asian Pacific countries.

语种英语
资助者Chugai Pharmaceutical ; MSD ; Sumitomo Dainippon Pharma ; Tanabe-Mitsubishi ; Ajinomoto ; Bristol-Myers Squibb ; Daiichi-Sankyo ; Janssen Pharmaceutical ; Bayer ; Abbvie ; Gilead ; GlaxoSmithKline ; Chugai Pharmaceutical ; MSD ; Sumitomo Dainippon Pharma ; Tanabe-Mitsubishi ; Ajinomoto ; Bristol-Myers Squibb ; Daiichi-Sankyo ; Janssen Pharmaceutical ; Bayer ; Abbvie ; Gilead ; GlaxoSmithKline
WOS记录号WOS:000363044000003
引用统计
被引频次:7[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/60559
专题北京大学第二临床医学院_北京大学肝病研究所
作者单位1.Yamanashi Hosp Cent & Kita Org, Kofu, Yamanashi 4008506, Japan
2.Univ Tokyo, Bunkyo Ku, Tokyo 1138655, Japan
3.Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, Chiba 2608677, Japan
4.Univ Queensland, Sch Med, Woolloongabba, Qld 4102, Australia
5.Bangabandhu Sheikh Mujib Med Univ, Dept Hepatol, Dhaka 1000, Bangladesh
6.Peking Univ, Peoples Hosp, Inst Hepatol, Beijing 100871, Peoples R China
7.Benha Univ, Dept Internal Med, GI Liver Div, Banha, Egypt
8.302 Hosp, Hong Kong SAR China Inst Translat Hepatol, Humanity & Hlth Med Ctr, Beijing, Peoples R China
9.302 Hosp, Ctr Liver Fibrosis Diag & Treatment Ctr, Beijing, Peoples R China
10.GB Pant Hosp, Dept Gastroenterol, New Delhi, India
11.Aga Khan Univ & Hosp, Dept Med, Karachi 74800, Pakistan
12.Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan
13.Ankara Univ, Sch Med, Dept Gastroenterol, TR-06100 Ankara, Turkey
推荐引用方式
GB/T 7714
Omata, Masao,Kanda, Tatsuo,Yokosuka, Osamu,et al. Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries[J]. HEPATOLOGY INTERNATIONAL,2015,9(4):486-507.
APA Omata, Masao.,Kanda, Tatsuo.,Yokosuka, Osamu.,Crawford, Darrell.,Al-Mahtab, Mamun.,...&Dokmeci, A. Kadir.(2015).Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.HEPATOLOGY INTERNATIONAL,9(4),486-507.
MLA Omata, Masao,et al."Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries".HEPATOLOGY INTERNATIONAL 9.4(2015):486-507.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Omata, Masao]的文章
[Kanda, Tatsuo]的文章
[Yokosuka, Osamu]的文章
百度学术
百度学术中相似的文章
[Omata, Masao]的文章
[Kanda, Tatsuo]的文章
[Yokosuka, Osamu]的文章
必应学术
必应学术中相似的文章
[Omata, Masao]的文章
[Kanda, Tatsuo]的文章
[Yokosuka, Osamu]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。